Medigene AG

Medigene AGverified

MDG1.DE

Price:

$0.1335

Market Cap:

$1.97M

Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with 2seventy bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immun...[Read more]

Industry

Biotechnology

IPO Date

2000-06-30

Stock Exchange

XETRA

Ticker

MDG1.DE

The PE Ratio as of December 2025 (TTM) for Medigene AG (MDG1.DE) is -0.11

According to Medigene AG’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -93.86% compared to the average of -1.80 of the last 4 quarters.

Medigene AG (MDG1.DE) Historical PE Ratio (quarterly & annually)

How has MDG1.DE PE Ratio performed in the past?

The mean historical PE Ratio of Medigene AG over the last ten years is -16.68. The current -0.11 PE Ratio has changed -33.87% with respect to the historical average. Over the past ten years (40 quarters), MDG1.DE's PE Ratio was at its highest in in the June 2022 quarter at 2.04. The PE Ratio was at its lowest in in the June 2016 quarter at -155.25.

Quarterly (TTM)
Annual

Average

-16.68

Median

-10.98

Minimum

-49.78

Maximum

-2.19

Medigene AG (MDG1.DE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Medigene AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 141.35%

Maximum Annual PE Ratio = -2.19

Minimum Annual Increase = -72.34%

Minimum Annual PE Ratio = -49.78

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.19-63.13%
2022-5.93-15.53%
2021-7.02135.74%
2020-2.98-39.18%
2019-4.90-72.34%
2018-17.71-55.88%
2017-40.14-19.38%
2016-49.78134.19%
2015-21.2642.36%
2014-14.93141.35%

Medigene AG (MDG1.DE) Average PE Ratio

How has MDG1.DE PE Ratio performed in the past?

The current PE Ratio of Medigene AG (MDG1.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-5.05

5-year avg

-4.60

10-year avg

-16.68

Medigene AG (MDG1.DE) PE Ratio vs. Peers

How is MDG1.DE’s PE Ratio compared to its peers?

Medigene AG’s PE Ratio is greater than Paion AG (-4.44), less than High Fusion Inc. (0), less than CytoTools AG (-0.01), greater than Epigenomics AG (-0.24), less than Molecule Holdings Inc. (-0.11), greater than Core One Labs Inc. (-0.28), greater than MagForce AG (-329.76), less than BZAM Ltd. (-0.00), greater than Aladdin Healthcare Technologies SE (-0.22), greater than co.don AG (-0.60),

Build a custom stock screener for Medigene AG (MDG1.DE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medigene AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medigene AG (MDG1.DE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medigene AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Medigene AG's PE Ratio?

How is the PE Ratio calculated for Medigene AG (MDG1.DE)?

What is the highest PE Ratio for Medigene AG (MDG1.DE)?

What is the 3-year average PE Ratio for Medigene AG (MDG1.DE)?

What is the 5-year average PE Ratio for Medigene AG (MDG1.DE)?

How does the current PE Ratio for Medigene AG (MDG1.DE) compare to its historical average?